AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Purple Biotech Ltd. Capital/Financing Update 2023

Nov 13, 2023

7004_rns_2023-11-13_3315275a-b49a-41c9-9426-ee9729045e01.htm

Capital/Financing Update

Opens in your device viewer

_________ false


�� "�	2 352
PURPLE BIOTECH LTD
Corporation no: 520031238	12724
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	13/11/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-103240	Time of broadcast: 23:37 23:37

Immediate report on other matterDon't use this form if there is more adequate one


Amendment No. 1 to FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PURPLE BIOTECH LTD
Attached file ea187966-f1a1_purplebioEDGAR9_bannerless_isa.pdf


�� F1
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 10/10/2023
Address: Oppenheimer, Science Park 4 , Rehovot 7670104 , Israel Tel: 03-9333121 , 03-9311321 Fax: 03-5097196
E-mail address: [email protected] Company site: www.kitovpharma.com

Previous names of reporting entity: KITOV PHARMA LTD, KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,

Name of the Signatory: Masas Ludmer Adi Position of Signatory in the reporting corporation: Company Controller Name of Employer Company:
Address: Menachem Begin Drive 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1
Israel